Symbiosis and AstraZeneca sign supply agreement for sterile manufacture of Covid-19 vaccine for clinical trials

This article was originally published here

Under the agreement, Symbiosis will provide AstraZeneca fast-track access to sterile vaccine drug product manufacturing capacity for clinical trial supply. The agreement follows AstraZeneca’s recent announcement of a

The post Symbiosis and AstraZeneca sign supply agreement for sterile manufacture of Covid-19 vaccine for clinical trials appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply